Suchergebnisse - "Venkatakrishnan, Karthik"

PubPharm (88)

1

Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor

enthalten in: Clinical pharmacokinetics | 2023

von Gupta, N. | Hanley, M. | Griffin, R. | +3

2

Brigatinib pharmacokinetics in patients with chronic hepatic impairment

enthalten in: Investigational new drugs | 2023

von Hanley, M. | Kerstein, D. | Tugnait, M. | +4

3

Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1

enthalten in: Cancer chemotherapy and pharmacology | 2022

von Vugmeyster, Y. | Grisic, A. | Wilkins, J. | +5

4

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2022

von Zhou, X. | Vaishampayan, U. | Mahalingam, D. | +7

5

Exposure–response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations

enthalten in: Cancer chemotherapy and pharmacology | 2022

von Xiong, W. | Hietala, S. | Nyberg, J. | +8

6

Effect of severe renal impairment on the pharmacokinetics of brigatinib

enthalten in: Investigational new drugs | 2021

von Gupta, N. | Hanley, M. | Kerstein, D. | +4

7

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2020

von Zhou, X. | Sedarati, F. | Faller, D. | +7

8

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

enthalten in: Clinical pharmacokinetics | 2020

von Gupta, N. | Wang, X. | Offman, E. | +5

9

Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor

enthalten in: Clinical pharmacokinetics | 2019

von Gupta, N. | Hanley, M. | Xia, C. | +3

10

Mass balance, routes of excretion, and pharmacokinetics of investigational oral [14C]-alisertib (MLN8237), an Aurora A kinase inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Zhou, X. | Pusalkar, S. | Chowdhury, S. | +4

1
2
3
4
5
6
7
8
9
Nächster »
[9]